Gonadorelin
Also known as: GnRH, LHRH
Gonadorelin is a synthetic form of gonadotropin-releasing hormone used in some diagnostic and fertility contexts. It is a prescription-only medicine in those settings.
- Category
- Reproductive / Hormonal
- Reported half-life
- Reported to be very short (minutes)
- Common forms
- Prescription injectable (clinical/diagnostic use), Preparations described in fertility research
- Research status
- A registered medicine in some contexts (diagnostic and certain fertility uses); prescription-only. Availability and indications vary by market.
- Last updated
- 21 June 2026
Claimed effects
The following effects are reported or claimed by users and in early research. They are not established medical facts and many are not supported by large human trials.
- Reported to stimulate the pituitary to release luteinising hormone and follicle-stimulating hormone
- Historically used in diagnostic testing of the reproductive hormone axis
- Studied in certain fertility-related contexts
How it is reported to work
Gonadorelin is described as a synthetic decapeptide identical to natural gonadotropin-releasing hormone that binds pituitary GnRH receptors. Given in a pulsatile pattern it is reported to prompt release of luteinising hormone and follicle-stimulating hormone. These descriptions come from clinical and diagnostic literature for a regulated, prescription-only agent.
Background
Gonadorelin is a synthetic form of gonadotropin-releasing hormone (GnRH/LHRH) used in some diagnostic and fertility contexts. It is a prescription-only medicine in those settings. This page is educational information, not medical advice, and does not recommend use.
What the research shows
Clinical and diagnostic literature reports that gonadorelin stimulates pituitary release of luteinising hormone and follicle-stimulating hormone. These are reported clinical findings within a regulated, prescription context.
| Feature | Reported status |
|---|---|
| Identity | Synthetic GnRH decapeptide |
| Typical setting | Diagnostic / fertility |
| Access | Prescription-only |
What people use it for (reported)
Gonadorelin is reported to be of interest in fertility and hormone-axis topics, reflecting its position upstream of the pituitary. Any use is intended to occur under medical supervision; online anecdotes are not validated outcomes and should not be read as established facts. Because the hormone axis operates through tightly regulated feedback loops, effects observed in a clinical diagnostic setting do not translate into safe self-directed use.
Things to be aware of
As a prescription-only medicine, gonadorelin is meant to be used under professional supervision. Reproductive hormone manipulation can have systemic effects, and self-sourced product purity cannot be verified.
If you have a fertility or hormonal concern, the appropriate step is to consult a qualified healthcare professional. This article does not endorse self-sourcing or self-administering gonadorelin.
Reported positives & side effects
Compiled from research and community reports. These are reported outcomes, not guarantees or medical advice, individual experiences vary widely.
Reported positives
- Reported to stimulate pituitary release of luteinising hormone and follicle-stimulating hormone in a physiological, pulsatile pattern
- Used clinically as a diagnostic tool to assess pituitary and reproductive-axis function
- Studied in fertility contexts to support induction of ovulation or spermatogenesis when delivered as prescribed
- Short duration of action is reported to allow flexible, supervised dosing in clinical settings
Common side effects
- Injection-site reactions such as redness, swelling or discomfort
- Headache reported in some recipients
- Flushing or a sensation of warmth
- Nausea or abdominal discomfort
- Light-headedness shortly after administration
Rare / serious side effects
- Allergic or hypersensitivity reactions, rarely including anaphylaxis
- Reported instances of abdominal pain associated with ovarian stimulation in fertility use
- Mood changes linked to altered hormone levels
Reported misuse & overdose risks
What has been reported to happen with overuse, excessive dosing, or long-term misuse of Gonadorelin. Listed so you can make an informed decision, not to suggest any use is safe.
- Off-label use by some bodybuilders to attempt to maintain testicular function or testosterone during or after anabolic steroid cycles, without medical supervision
- Self-dosing with grey-market product of unverified identity and purity, risking contamination or incorrect concentration
- Incorrect dosing frequency that can paradoxically suppress rather than stimulate the hormone axis, disrupting natural reproductive function
- Combining with other hormonal agents without monitoring, increasing risk of endocrine disruption
Reported results timeline
Roughly how long people report it takes to notice effects. A general guide from reports, not a promise, and not advice. Reported to act acutely, prompting pituitary hormone release within minutes to hours, with clinical effects assessed over subsequent weeks.
First effects
acute pituitary hormone release reported within minutes to hours
Noticeable change
shifts in measured LH/FSH or downstream hormones over early weeks
Clear results
clinical objectives such as fertility-axis response assessed over weeks
Commonly reported dosing & protocol
Reported figures only, NOT a recommendation or dosing advice. These are numbers people report using, compiled for education so you can make an informed decision. We do not advise anyone to take Gonadorelin. Many peptides are not approved for human use in Australia. Speak to a qualified healthcare professional.
| Route | Subcutaneous or intravenous injection (clinician-administered for diagnostic and fertility use; prescriber-directed) |
|---|---|
| Typical reported dose | Reported diagnostic stimulation dose is approximately 100 mcg given IV or SubQ. Pulsatile fertility use via an infusion pump is reported at roughly 5-20 mcg per pulse every ~90 minutes. Off-label community use is reported around 100-200 mcg per dose. |
| Frequency | Single dose for diagnostic testing; pulsatile (every ~90 minutes via pump) for reported fertility use; off-label community reports vary |
| Cycle length | Determined by clinical indication and prescriber; diagnostic use is a single administration |
Reported reconstitution (mg → units)
For a reconstituted vial, a 2 mg vial plus 2 mL bacteriostatic water gives 1 mg/mL. A 100 mcg dose is about 0.1 mL, which is roughly 10 units on a 100-unit insulin syringe. Figures are illustrative; this is a prescription-only medicine.
Work out the units for your vial → CalculatorReported clinical use is prescriber-directed and tailored to the indication: diagnostic testing typically uses a single supervised dose, while fertility-related use is reported to employ pulsatile dosing via a pump under specialist supervision. This is reported information about a prescription-only medicine, not advice.
Best used with / commonly stacked with
Combinations people report using together. Reported, not recommended, stacking can increase risks.
Testosterone replacement context
Reported off-label alongside testosterone-based protocols in attempts to preserve natural testicular signalling
Both act upstream on the reproductive hormone axis and are discussed together in fertility research
Related GnRH-targeting agents discussed together in reproductive endocrinology
Safety notes
Gonadorelin is a prescription-only medicine, and its use is intended to occur under qualified medical supervision. Manipulating reproductive hormones can have systemic effects. Anyone with a fertility or hormonal concern should consult a qualified healthcare professional rather than self-experimenting.